The new International Rhabdomyosarcoma classification, its progenitors, and considerations beyond morphology

Advances in Anatomic Pathology

Volumn 4, Issue 1, 1997, Pages 1-16

  Coffin, Cheryl M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar rhabdomyosarcoma; Childhood cancer; Embryonal rhabdomyosarcoma; Soft tissue sarcoma; Tumor classification; Tumor diagnosis

Indexed keywords

EID: 0002641937     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-199701000-00001     Document Type: Review

References (82)

1. Harms D. Soft tissue sarcomas in the Kiel Pediatric Tumor Registry. In: Harms D, Schmidt D, eds. Current topics in pathology; vol 89. Berlin: Springer-Verlag, 1995:31-43.
2. Ruymann FB, Grufferman S. Introduction and epidemiology of soft tissue sarcomas. In: Maurer HM, Ruymann FB, Pochedly C, eds. Rhabdomyosarcoma and related tumors in children and adolescents. Boca Raton, FL: CRC, 1991:3-18.
3. Raney RB, Mays DM, Tefft M, et al. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG (eds). Principles and practice of pediatric oncology. Philadelphia: Lippincott, 1993:769-94.
4. Stout AP. Rhabdomyosarcoma of the skeletal muscles. Cancer 1946;123:447-472.
5. Horn RC, Enterline HT. Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases. Cancer 1958;11:181-99.
6. Palmer NG, Sachs N, Foulkes M. Histopathology and prognosis in rhabdomyosarcoma [Abstract]. Proc Am Soc Clin Oncol 1981;1:113-4.
7. Palmer NG, Sachs N, Foulkes M. Histopathology and prognosis in rhabdomyosarcoma (IRS-1) (Abstract]. Proc Am Soc Clin Oncol 1982;1:170.
8. Caillaud JM, Gerard-Marchant R, Marsden HB, et al. Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology Pathology Panel. Med Pediatr Oncol 1989;17:391-400.
9. Tsokos M. The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994;11:26-38.
10. Dehner LP. Favorable vs unfavorable histologic appearance: the lexicon of pathologic grading of solid malignant neoplasms in children. Arch Pathol Lab Med 1992;116:817-20.
11. Weiss SW. Histological typing of soft tissue tumors. Geneva: Springer-Verlag, World Health Organization, 1995:29-30.
12. Newton WA, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcomas and related sarcomas: pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 1995;76:1073-85.
13. Asmar L, Gehan EA, Newton WA, et al. Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: report of an international study of four pathology classifications. Cancer 1994;74:2579-88.
14. Gaiger AM, Soule FH, Newton WA. Pathology of rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1971-1978. Natl Cancer Inst Monogr 1981;56:19-27.
15. Bale PM, Parsons RE, Stevens MM. Diagnosis and behavior of juvenile rhabdomyosarcoma. Hum Pathol 1983;14:596-611.
16. Bale PM, Parsons MM. Pathology and behavior of juvenile rhabdomyosarcoma. In: Finegold M, ed. Pomology of neoplasia in children and adolescents. Philadelphia: WB Saunders, 1986:196-222.
17. Hawkins HK, Camacho-Velasquez JV. Rhabdomyosarcoma in children: correlation of form and prognosis in one institution's experience. Am J Surg Pathol 1987;11:531-42.
18. Hays DM, Shimada H, Raney RB Jr, et al. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents. Cancer 1988;61:1883-903.
19. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I: a final report. Cancer 1988;61:209-20.
20. Newton WA, Soule EH, Hamoudi AB, et al. Histopathology of childhood sarcomas: Intergroup Rhabdomyosarcoma Studies I and II - clinicopathologic correlation. J Clin Oncol 1988;6:67-75.
21. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-22.
22. Crist W, Gehan EA, Ragab AH, et al. The Intergroup Rhabdomyosarcoma Study-III. J Clin Oncol 1995;13:610-30.
23. Pappo AS, Shapiro DN, Crist WM, Maurer HM. Biology and therapy of rhabdomyosarcoma. J Clin Oncol 1995;13:2123-9.
24. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St. Louis: Mosby-Year Book, 1995:539-77.
25. Eusebi V, Ceccarelli C, Gorza L, Schiaffino S, Bussolati G. Immunohistochemistry of rhabdomyosarcoma: the use of four different markers. Am J Surg Pathol 1986;10:293-9.
26. Eusebi V, Rilke F, Ceccarelli C, Fedeli F, Schiaffino S, Bussolati G. Fetal heavy chain skeletal myosin: an oncofetal antigen expressed by rhabdomyosarcoma. Am J Surg Pathol 1986;10:680-6.
27. Kahn HJ, Yeger H, Kassim O, et al. Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma: increased frequency of diagnosis over routine laboratory methods. Cancer 1983;51:1897-903.
28. Kindblom LG, Scidal T, Karlsson K. Immunohistochemical localization of myoglobin in human muscle tissue and embryonal and alveolar rhabdomyosarcoma. Acta Pathol Microbiol Stand [A] 1982;90:167-74.
29. Mukai K, Rosai J, Hallaway BE. Localization of myoglobin in normal and neoplastic human skeletal muscle cells using an immunoperoxidase technique. Am J Surg Pathol 1979;3:373-6.
30. Ohm A, Ghose T. Use of antiskeletal muscle antibody from myasthenic patients in the diagnosis of childhood rhabdomyosarcoma. Am J Surg Pathol 1987;11:272-6.
31. Fisher C. The value of electron microscopy and immunohistochemistry in the diagnosis of soft tissues sarcomas: a study of 200 cases. Histopathology 1990;16:441-54.
32. Parham DM, Webber B, Holt H, Williams WK, Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Cancer 1991;67:3072-80.
33. Dias P, Dilling M, Houghton P. The molecular basis of skeletal muscle differentiation. Semin Diagn Pathol 1994;11:3-14.
34. mic2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelium. Am J Surg Pathol 1994;18:486-94.
35. Mierau GW, Favara BE. Rhabdomyosarcoma in children: ultrastructural study of 31 cases. Cancer 1980;46:2035-40.
36. Parham DP. The molecular biology of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994;11:39-46.
37. Scrable H, Witte D, Shimada H, et al. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1989;1:23-35.
38. Driman D, Thorner PS, Greenberg ML, Chilton-MacNeill S, Squire J. MYCN gene amplification in rhabdomyosarcoma. Cancer 1994;73:2231-7.
39. Barr FG, Chatten J, D'Cruz C, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995;273:553-7.
40. Stobbe GD, Dargeon HW. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer 1950;3:826-36.
41. Horn RC, Yakovac WC, Kaye R, Koop CE. Rhabdomyosarcoma (sarcoma botryoides) of common bile duct: report of a case. Cancer 1955;8:468-77.
42. Riopelle JL, Theriault JP. Sur une forme meconnue de sarcome des parties molles: le rhabdomyosarcome alveolaire. Ann Anat Path 1956;1:88-111.
43. Tsokos M, Triche TJ. Immunocytochemical and ultrastructural study of primitive, "solid variant" rhabdomyosarcoma. Lab Invest 1986;54:16A.
44. Enzinger FM, Lattes R, Torloni H. Histological typing of soft tissue tumors. Geneva: World Health Organization, 1969.
45. Dias P, Kumar P, Marsden HB, et al. Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas. Br J Cancer 1987;56:361-5.
46. Schmidt D, Reimann O, Treuner J, Harms D. Cellular differentiation and prognosis in embryonal rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma Study 1981 (CWS 81). Virchows Arch [A] 1986;409:183-94.
47. Tsokos M, Webber BL, Parham DM, et al. Rhabdomyosarcoma: a new classification scheme related to prognosis. Arch Pathol Lab Med 1992;116:847-56.
48. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors: a subgroup of small round cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-9.
49. Cavazzana AO, Ninfo V, Roberts J, Triche TJ. Peripheral neuroblastoma: a light microscopic, immunocytochemical, and ultrastructural study. Mod Pathol 1992;5:71-8.
50. Miser JS, Kinsella TJ, Triche TJ, et al. Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol 1987;5:1752-8.
51. Marina NM, Etcubanas E, Parham DM, et al. Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. Cancer 1989;64:1952-60.
52. Schmidt D, Herrmann C, Jurgen SH, Harms D. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. Cancer 1991;68:2251-9.
53. Kushner BH. Hajdu SI, Gulati SC, et al. Extracranial primitive neuroectodermal tumor. Cancer 1991;67:1825-9.
54. Hiti AL, Bogenmann E, Gonzales F, Jones PA. Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol Cell Biol 1989;9:4722-30.
55. Dias P, Kumar P, Marsden HB, Gaitamaneni HR, Heighway J, Kumar S. N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int J Cancer 1990;45:593-6.
56. Douglass EC, Valentine M, Etcubanas E, et al. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 1987;45:148-55.
57. Valentine M, Douglass EC, Look AT. Closely linked loci on the long arm of chromosome 13 flank a specific 2;13 translocation breakpoint in childhood rhabdomyosarcoma. Cytogenet Cell Genet 1989;52:128-32.
58. Biegel JA, Meek RS, Parmiter AH, Conard K, Emanuel BS. Chromosomal translocation t(1;13) (p36;q14) in a case of rhabdomyosarcoma. Genes Chromosomes Cancer 1991;3:483-4.
59. Douglass EC, Rowe ST, Valentine M, et al. Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 1991;3:480-2.
60. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T. Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer 1992;5:299-310.
61. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS. Rearrangement of the PAX3 paired box gene in the pediatric solid tumor alveolar rhabdomyosarcoma. Nature Genet 1993;3:113-7.
62. Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nature Genet 1993;5:230-5.
63. Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 1993;53:5108-12.
64. Davis RJ, D'Cruz CM, Lovell MA, Briegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t(1;13) (p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994;54:2869-72.
65. Parham DM, Shapiro DN, Downing JR, Webber BL, Douglass EC. Solid alveolar rhabdomyosarcoma with the t(2,13): report of two cases with diagnostic implications. Am J Surg Pathol 1994;18:474-8.
66. Barr FG, Nauta LE, Davis RJ, Schafer BW, Nycum LM, Biegel JA. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mot Genet 1996;5:15-21.
67. Sublett JE, In-Sang J, Shapiro DN. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Oncogene 1995;11:545-52.
68. Wang-Wuu S, Soukup S, Ballard E, et al. Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res 1988;48:983-7.
69. Douglass EC, Shapiro DN, Valentine M, et al. Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 1993;21:83-7.
70. Ogose A, Motoyama T, Hotta T. In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line. Virchows Arch [A] 1995;426:385-91.
71. Koufos A, Hansen MF, Copeland NG, et al. Loss of heterozygosity in three embryonal tumors suggests a common pathogenetic mechanism. Nature 1985;316:330-4.
72. Loh WE, Scrable HJ, Livanos E, et al. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc Natl Acad Sci USA 1992;89:1755-9.
73. Koi M, Johnson LA, Kalikin LM, et al. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science 1993;260:361-7.
74. Shapiro DN, Parham DM, Douglass EC, et al. Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 1991;9:159-66.
75. Wijnaendts LCD, van der Linden JC, van Diest PJ, et al. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas. J Clin Pathol 1993;46:948-52.
76. Kilpatrick SE, Teot LA, Geisinger KR, et al. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma: comparison of flow cytometry and image analysis. Cancer 1994;74:3227-33.
77. Mathieu MC, Niggli F, Vielh P, et al. Prognostic value of flow cytometric DNA ploidy in childhood rhabdomyosarcomas enrolled in SIOP-MMT 89 study. Med Pediatr Oncol 1994;23:223.
78. Niggli FK, Powell JE, Parkes SE, et al. DNA ploidy and proliferative activity (S-phase) in childhood soft tissue sarcomas: their value as prognostic indicators. Br J Cancer 1994;69:1106-10.
79. Felix CA, Chavez Kappel C, Mitsudomi T, et al. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 1992;52:2243-7.
80. Chan HSL, Thorner PS, Haddad G, et al. Immunohistochemical detection of p-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990;8:689-704.
81. Cavazzana AO, Schmidt D, Ninfo V, et al. Spindle cell rhabdomyosarcoma: a prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 1992;16:229-35.
82. Leuschner I, Newton WA, Schmidt D, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: a report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 1993;17:221-30.